ORIGINAL RESEARCH
Published on 04 Sep 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)
doi 10.3389/fphar.2024.1457363
- 2,966 views
- Frontiers in Pharmacology
- Translational Pharmacology
- Research Topics
- Optimizing GLP-1 Receptor Agonist Use: Mechanisms, Clinical Applications, and Safety Profiles
Optimizing GLP-1 Receptor Agonist Use: Mechanisms, Clinical Applications, and Safety Profiles
3,351
Total downloads
15k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CLINICAL TRIAL
Published on 22 Aug 2024
Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial
doi 10.3389/fphar.2024.1433587
- 1,028 views
ORIGINAL RESEARCH
Published on 16 Aug 2024
The GLP-1 receptor agonist exendin-4 reduces taurine and glycine in nucleus accumbens of male rats, an effect tentatively involving the nucleus tractus solitarius
doi 10.3389/fphar.2024.1439203
- 986 views
ORIGINAL RESEARCH
Published on 08 Jul 2024
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
doi 10.3389/fphar.2024.1416985
- 2,887 views
- 4 citations
CASE REPORT
Published on 18 Apr 2024
GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report
doi 10.3389/fonc.2024.1392375
- 5,959 views
- 1 citation
Published in
Frontiers in Pharmacology
- Translational Pharmacology
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.
Impact
- 15kTopic views
- 10kArticle views
- 3,351Article downloads